TRAW icon

Traws Pharma
TRAW

Overview Fund Activity

11 hedge funds and large institutions have $3.8M invested in Traws Pharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 18 closing their positions.

Holders
11
Holders Change
-18
Holders Change %
-62.07%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
10
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$3.56M
2
Bank of America
2
Bank of America
North Carolina
$12.6K
3
TRCT
3
Tower Research Capital (TRC)
New York
$2.23K
4
BlackRock
4
BlackRock
New York
$58.5K

Top Sellers

1
Geode Capital Management
1
Geode Capital Management
Massachusetts
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
State Street
4
State Street
Massachusetts
$0
5
UBS Group
5
UBS Group
Switzerland
$3.7K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
– – -128 Closed
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– – -55 Closed
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
– – -3 -100%
Fidelity Investments
29
Fidelity Investments
Massachusetts
– – -1 -100%
CFGS
30
Concourse Financial Group Securities
Alabama
– – – –
1
2